12 Jun After Heart Attack: Encouraging Stem Cells To Regenerate Damaged Muscle
MedicalResearch.com Interview with
Dr. Takuji Toyama MD
Division of Cardiology
Gunma Prefectural Cardiovascular Center
MedicalResearch: What are the main findings of the study?
Dr. Toyama: The early start of granulocyte colony-stimulating factor (G-CSF) therapy in acute myocardial infarction ( AMI) patients can improve myocardial perfusion, fatty acid metabolism and cardiac function in subacute and follow-up periods.
MedicalResearch: What should clinicians and patients take away from your report?
Dr. Toyama: Clinicians should try to use G-CSF in the treatment of acute myocardial infarction.
MedicalResearch: What recommendations do you have for future research as a result of this study?
Dr. Toyama: In the future, we need to study the long-term effects of G-CSF in a large
number of patients with acute myocardial infarction.
Is the granulocyte colony-stimulating factor therapy in the earliest phase effective to rescue patients with acute myocardial infarction?
Takuji Toyama1, Hiroshi Hoshizaki1, Hakuken Kan1, Ren Kawaguchi1, Hitoshi Adachi1, Shigeru Ohsima1, Masahiko Kurabayashi2; 1Division of Cardiology, Gunma Prefectural Cardiovascular Center, Maebashi, Japan, 2Department of Cardiovascular Medicine, Gunma University School of Medicine, Maebashi, Japan.